254 related articles for article (PubMed ID: 36235659)
1. Effects of Maternal Gut Microbiota-Targeted Therapy on the Programming of Nonalcoholic Fatty Liver Disease in Dams and Fetuses, Related to a Prenatal High-Fat Diet.
Yu HR; Sheen JM; Hou CY; Lin IC; Huang LT; Tain YL; Cheng HH; Lai YJ; Lin YJ; Tiao MM; Tsai CC
Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235659
[TBL] [Abstract][Full Text] [Related]
2. Metformin ameliorates maternal high-fat diet-induced maternal dysbiosis and fetal liver apoptosis.
Huang SW; Ou YC; Tang KS; Yu HR; Huang LT; Tain YL; Lin IC; Sheen JM; Hou CY; Tsai CC; Tiao MM
Lipids Health Dis; 2021 Sep; 20(1):100. PubMed ID: 34496884
[TBL] [Abstract][Full Text] [Related]
3. Hypertension Programmed by Perinatal High-Fat Diet: Effect of Maternal Gut Microbiota-Targeted Therapy.
Hsu CN; Hou CY; Chan JYH; Lee CT; Tain YL
Nutrients; 2019 Dec; 11(12):. PubMed ID: 31810197
[TBL] [Abstract][Full Text] [Related]
4. Maternal Obesity Related to High Fat Diet Induces Placenta Remodeling and Gut Microbiome Shaping That Are Responsible for Fetal Liver Lipid Dysmetabolism.
Wang YW; Yu HR; Tiao MM; Tain YL; Lin IC; Sheen JM; Lin YJ; Chang KA; Chen CC; Tsai CC; Huang LT
Front Nutr; 2021; 8():736944. PubMed ID: 34977107
[No Abstract] [Full Text] [Related]
5. Resveratrol treatment improves the altered metabolism and related dysbiosis of gut programed by prenatal high-fat diet and postnatal high-fat diet exposure.
Huang YC; Huang LT; Sheen JM; Hou CY; Yeh YT; Chiang CP; Lin IC; Tiao MM; Tsai CC; Lin YJ; Chen CC; Tain YL; Yu HR
J Nutr Biochem; 2020 Jan; 75():108260. PubMed ID: 31707285
[TBL] [Abstract][Full Text] [Related]
6. Maternal Administration of Probiotic or Prebiotic Prevents Male Adult Rat Offspring against Developmental Programming of Hypertension Induced by High Fructose Consumption in Pregnancy and Lactation.
Hsu CN; Lin YJ; Hou CY; Tain YL
Nutrients; 2018 Sep; 10(9):. PubMed ID: 30181501
[TBL] [Abstract][Full Text] [Related]
7. Spinach consumption ameliorates the gut microbiota and dislipaemia in rats with diet-induced non-alcoholic fatty liver disease (NAFLD).
Elvira-Torales LI; Periago MJ; González-Barrio R; Hidalgo N; Navarro-González I; Gómez-Gallego C; Masuero D; Soini E; Vrhovsek U; García-Alonso FJ
Food Funct; 2019 Apr; 10(4):2148-2160. PubMed ID: 30938723
[TBL] [Abstract][Full Text] [Related]
8. Reprogramming Effects of Postbiotic Butyrate and Propionate on Maternal High-Fructose Diet-Induced Offspring Hypertension.
Tain YL; Hou CY; Chang-Chien GP; Lin S; Tzeng HT; Lee WC; Wu KLH; Yu HR; Chan JYH; Hsu CN
Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049522
[TBL] [Abstract][Full Text] [Related]
9. Transgenerational impact of maternal obesogenic diet on offspring bile acid homeostasis and nonalcoholic fatty liver disease.
Thompson MD; Derse A; Ferey J; Reid M; Xie Y; Christ M; Chatterjee D; Nguyen C; Harasymowicz N; Guilak F; Moley KH; Davidson NO
Am J Physiol Endocrinol Metab; 2019 Apr; 316(4):E674-E686. PubMed ID: 30860882
[TBL] [Abstract][Full Text] [Related]
10. High-fat diet intake modulates maternal intestinal adaptations to pregnancy and results in placental hypoxia, as well as altered fetal gut barrier proteins and immune markers.
Gohir W; Kennedy KM; Wallace JG; Saoi M; Bellissimo CJ; Britz-McKibbin P; Petrik JJ; Surette MG; Sloboda DM
J Physiol; 2019 Jun; 597(12):3029-3051. PubMed ID: 31081119
[TBL] [Abstract][Full Text] [Related]
11. Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier.
Zhou D; Pan Q; Xin FZ; Zhang RN; He CX; Chen GY; Liu C; Chen YW; Fan JG
World J Gastroenterol; 2017 Jan; 23(1):60-75. PubMed ID: 28104981
[TBL] [Abstract][Full Text] [Related]
12. Sex-specific maternal calcium requirements for the prevention of nonalcoholic fatty liver disease by altering the intestinal microbiota and lipid metabolism in the high-fat-diet-fed offspring mice.
Li P; Yan K; Chang X; Chen X; Wang R; Fan X; Tang T; Zhan D; Qi K
Gut Microbes; 2020 Nov; 11(6):1590-1607. PubMed ID: 32576050
[TBL] [Abstract][Full Text] [Related]
13. Erchen Decoction alleviates obesity-related hepatic steatosis via modulating gut microbiota-drived butyric acid contents and promoting fatty acid β-oxidation.
Zhang L; Chen N; Zhan L; Bi T; Zhou W; Zhang L; Zhu L
J Ethnopharmacol; 2023 Dec; 317():116811. PubMed ID: 37336336
[TBL] [Abstract][Full Text] [Related]
14. Maternal Garlic Oil Supplementation Prevents High-Fat Diet-Induced Hypertension in Adult Rat Offspring: Implications of H2S-Generating Pathway in the Gut and Kidneys.
Hsu CN; Hou CY; Chang-Chien GP; Lin S; Tain YL
Mol Nutr Food Res; 2021 Jun; 65(11):e2001116. PubMed ID: 33547712
[TBL] [Abstract][Full Text] [Related]
15. Maternal Metformin Treatment Reprograms Maternal High-Fat Diet-Induced Hepatic Steatosis in Offspring Associated with Placental Glucose Transporter Modifications.
Huang CF; Tiao MM; Lin IC; Huang LT; Sheen JM; Tain YL; Hsu CN; Tsai CC; Lin YJ; Yu HR
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430717
[TBL] [Abstract][Full Text] [Related]
16. Altered Gut Microbiota and Its Metabolites in Hypertension of Developmental Origins: Exploring Differences between Fructose and Antibiotics Exposure.
Hsu CN; Chan JYH; Wu KLH; Yu HR; Lee WC; Hou CY; Tain YL
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800916
[TBL] [Abstract][Full Text] [Related]
17. Maternal Betaine Supplementation Mitigates Maternal High Fat Diet-Induced NAFLD in Offspring Mice through Gut Microbiota.
Sun L; Tan X; Liang X; Chen H; Ou Q; Wu Q; Yu X; Zhao H; Huang Q; Yi Z; Wei J; Wu F; Zhu H; Wang L
Nutrients; 2023 Jan; 15(2):. PubMed ID: 36678155
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota modulation as a promising therapy with metformin in rats with non-alcoholic steatohepatitis: Role of LPS/TLR4 and autophagy pathways.
Ahmed LA; Salem MB; Seif El-Din SH; El-Lakkany NM; Ahmed HO; Nasr SM; Hammam OA; Botros SS; Saleh S
Eur J Pharmacol; 2020 Nov; 887():173461. PubMed ID: 32758573
[TBL] [Abstract][Full Text] [Related]
19. Early intervention with probiotics and metformin alleviates liver injury in NAFLD rats via targeting gut microbiota dysbiosis and p-AKT/mTOR/LC-3II pathways.
Seif El-Din SH; Salem MB; El-Lakkany NM; Hammam OA; Nasr SM; Okasha H; Ahmed LA; Saleh S; Botros SS
Hum Exp Toxicol; 2021 Sep; 40(9):1496-1509. PubMed ID: 33678036
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol ameliorates maternal and post-weaning high-fat diet-induced nonalcoholic fatty liver disease via renin-angiotensin system.
Tiao MM; Lin YJ; Yu HR; Sheen JM; Lin IC; Lai YJ; Tain YL; Huang LT; Tsai CC
Lipids Health Dis; 2018 Jul; 17(1):178. PubMed ID: 30055626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
